Life Time Group Holdings, Inc. (LTH) Dividend History

Company News

• Lithium Ionic Executes Definitive Agreement for US$20 Million Royalty Financing with Appian Capital

  TORONTO, June 28, 2024 (GLOBE NEWSWIRE) -- Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Lithium Ionic Bandeira Corp. (the “Grantor”), has executed a definitive royalty agreement (the “Royalty Agreement”) with ANRF LI (JSY) Ltd., an affiliate of Appian Capital Advisory LLP (“Appian”), granting a 2.25% gross revenue royalty in exchange for upfront cash consideration of US$20,000,000 (the “Royalty”). This agreement is substantially in line with the terms previously disclosed in the Company’s May 30, 2024, news release. Appian is an investment advisor to long-term, value-focused private capital funds that invest solely in mining and mining-related companies.

  GlobeNewswire Inc.
• Implied Volatility Surging for Life Time Group (LTH) Stock Options

  Investors need to pay close attention to Life Time Group (LTH) stock based on the movements in the options market lately.

  Zacks Investment Research
• Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

  Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. Bumble reported quarterly losses of 19 cents per share which missed the analyst consensus estimate of 12 cents per share. The company reported quarterly sales of $273.64 million which missed the analyst consensus estimate of $275.29 million. Bumble shares dipped 11.6% to $11.65 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Vivani Medical, Inc. (NASDAQ: VANI) shares jumped 289% to $3.93 after the company announced preclinical data on weight loss effects for NPM-115 and disclosed that semaglutide is the active pharmaceutical ingredient in NPM-139. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) climbed 190% to $2.4598. Adial Pharmaceuticals secured new US patent covering lead product for alcohol use disorder. vTv Therapeutics Inc. (NASDAQ: VTVT) gained 112% to $17.65 after the company announced a $51 million private placement from healthcare-focused institutional investors and the JDRF T1D Fund. Bit Brother Limited (NASDAQ: BETS) shares rose 63.7% to $4.0750. Beyond Meat, Inc. (NASDAQ: BYND) climbed 45% to $10.90 as the company reported stronger-than-expected sales for its fourth quarter. Incannex Healthcare Inc. (NASDAQ: IXHL) gained 43.6% to $6.06 after the company announced its Psi-GAD1 trial met its primary endpoint. Bandwidth Inc. (NASDAQ: BAND) surged 43.3% to $17.41 after the company reported better-than-expected fourth quarter financial results and issued FY24 revenue guidance above estimates. Imunon, Inc. (NASDAQ: IMNN) climbed 38% to $0.98. Applied Therapeutics, Inc. (NASDAQ: APLT) surged 36% to $7.59 after the company announced FDA acceptance and priority review of the NDA for govorestat for the treatment of Classic Galactosemia. The company also announced a $100 million private placement. Movella Holdings Inc. (NASDAQ: MVLA) gained 33.5% to $0.33. LifeStance Health Group, Inc. (NASDAQ: LFST) gained 31.5% to $8.81 following strong quarterly sales. AirNet Technology Inc. (NASDAQ: ANTE) rose 31.3% to $1.05. AirNet announced changes in senior management team. Polestar Automotive Holding UK PLC (NASDAQ: PSNY) rose 29.9% to $1.9350. Polestar secured $1 billion external funding. Editas Medicine, Inc. (NASDAQ: EDIT) gained 27.7% to $11.31 after the company reported better-than-expected fourth-quarter financial results. TG Therapeutics, ...

  Benzinga

  Featured Companies: AAP ACMR ADIL ADT AGO ALHC APLT BAND BGS BMBL BYND CNXC COCO DDD EB EBAY EDIT FLYW GTLS HY IAS IFBD IMNN INGN JL KITT LAZR LFST LMND M MSTR NRDY NVAX OGEN PAYO PGNY PSNY RBOT RVLV RXRX SAM SMXT SSP TGTX URBN VANI VTVT VTYX
• 3 Gym Stocks to Cash In on Dieters’ New Year’s Resolutions

  Investing.com

  Featured Companies: PLNT XPOF
• Why Life Time's Stock Dropped 13.6% Today

  Revenue is up, but the bottom line leaves a lot to be desired.

  The Motley Fool